HopeAI, an emerging leader in applying artificial intelligence (AI) to accelerate new drug development, has officially joined the prestigious Mayo Clinic Platform Accelerate program. This partnership grants HopeAI access to Mayo Clinic’s world-class real-world data (RWD) platform, enabling faster, smarter, and more confident clinical trial design. Bringing a new drug to market is one of the most…
Following top analyst recognition, ScienceLogic expands Skylar Analytics and enhances platform capabilities to accelerate AI-driven IT outcomes ScienceLogic®, a leader in intelligent automation and observability, today announced a series of updates to its solution suite, including new capabilities for the ScienceLogic AI Platform and Skylar AI Suite that redefine automation, observability, secure government operations, and low-code development. These latest…
Soracom Query delivers IoT data insights, Flux Video Analysis unlocks advanced IoT use cases, and Flux App Templates generates IoT workflows on demand Soracom, Inc., a global provider of advanced IoT connectivity solutions with full MVNO capability, today announced two new platform services that leverage GenAI capabilities to accelerate IoT development and support leading-edge video…
Amalgam Rx, Inc., a leader in enabling data-driven healthcare decision making, today announced a $20 million credit investment from Catalio Capital Management, a leading investment firm dedicated to backing innovative healthcare companies. The funding will accelerate the scaling of Amalgam’s Medical-Grade AI solutions to further empower patients in their daily lives and providers in their…
The rise of agentic AI fuels AI in ways traditional AI can’t. The scope of AI is plentiful, but there’s a small subsection of tasks Agentic AI is just better at, thanks to its increased levels of autonomy. With the improvement in capability comes a fresh look at how to manage such a tool within…
Study Confirms Regulatory-Grade Performance and AI-Driven Clinical Utility to Advance Precision Oncology and Patient Stratification for Drug Development BostonGene, a leader in AI-powered solutions for drug discovery and development, today announced the publication of a pivotal study, “Clinical and analytical validation of a combined RNA and DNA exome assay across a large tumor cohort,” in Communications…
Heavily shareholder-aligned board and management team completely replaces ReShape team as Vyome prepares for public listing on August 15, 2025 Vyome Therapeutics, Inc., a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, today announced its post-closing Board of Directors, expected to take control of the ReShape…
Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced that its platform, Techcyte Fusion (research use only (RUO) in the US, CE-IVDD-marked in Europe), now includes Modella AI, a biomedical artificial intelligence company at the forefront of computational pathology, as a partner in the Techcyte Fusion Partner Program. This collaboration brings…
Secure Data Preparation and Scalable Solutions Enable Customers To Accelerate Databricks’ Implementation Chetu, a global leader in digital intelligence and software solutions, announced today the expansion of its partnership with Databricks, the Data and AI company, with the launch of new data intelligence migration solutions. These services help businesses deploy Databricks’ powerful Data Intelligence Platform through…
Anthropic has detailed its safety strategy to try and keep its popular AI model, Claude, helpful while avoiding perpetuating harms. Central to this effort is Anthropic’s Safeguards team; who aren’t your average tech support group, they’re a mix of policy experts, data scientists, engineers, and threat analysts who know how bad actors think. However, Anthropic’s…